Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with NAFLD have an elevated risk of cancer, largely due to high liver cancer incidence.
Weight-loss surgery especially reduced obesity-related cancers in people with liver cirrhosis.
People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy.
The disease has similar prevalence across high-income and low- and middle-income nations.
Unexpectedly, liver steatosis was also associated with a greater chance of achieving HBsAg seroclearance.
Alcoholism-related liver disease was a growing problem even before COVID-19, but the pandemic has dramatically added to the toll.
Hepatitis A and E usually resolve on their own, but hepatitis B and C can cause serious liver disease, including cirrhosis and liver cancer.
Compared to other racial and ethnic groups, Blacks are also less likely to be diagnosed early.
A Mediterranean diet could help reduce the risk of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Areas with lower population density have not seen the same slowdown as urban areas.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.
The best-performing combo, firsocostat and cilofexor, showed benefits despite missing the main study endpoint.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.